Literature DB >> 3841572

Inhibition of steroidogenic cytochrome P-450 enzymes in rat testis by ketoconazole and related imidazole anti-fungal drugs.

P B Kan, M A Hirst, D Feldman.   

Abstract

Ketoconazole, an imidazole antifungal drug, has previously been shown to diminish testosterone and cortisol production in patients as well as rat and mouse cells in vitro. Inhibition of adrenal mitochondrial cytochrome P-450 enzymes was demonstrated. In this study we tested several imidazole antifungal drugs and examined the individual steps in testicular steroidogenesis to determine which enzymes in the androgen pathway were blocked. In addition, we studied 25-hydroxyvitamin D 24-hydroxylase activity in cultured pig kidney cells (LLC-PK1) to assess a mitochondrial P-450 enzyme in another organ. All imidazoles tested inhibited both total testosterone production and 24-hydroxylase activity but the relative potencies differed. We next studied the individual testicular enzymatic steps between cholesterol and testosterone. Ketoconazole inhibited cholesterol-side-chain-cleavage enzyme (mitochondrial) and C-17,20 lyase (microsomal). The three inhibited enzymes (two testicular and one renal) are all P-450 cytochromes. Testicular 17-hydroxylase, also a P-450 cytochrome, was not inhibited even at high doses of ketoconazole. This is an interesting finding because the testicular hydroxylase and lyase have been shown to be a single protein. Non-cytochrome P-450 enzymes in the androgen pathway were not inhibited. The results demonstrate that several imidazole antifungal drugs all inhibit both microsomal and mitochondrial cytochrome P-450 enzymes in multiple organs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3841572     DOI: 10.1016/0022-4731(85)90062-7

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  9 in total

1.  High-dose itraconazole in the treatment of severe mycoses.

Authors:  P K Sharkey; M G Rinaldi; J F Dunn; T C Hardin; R J Fetchick; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

Review 2.  The endocrine effects of ketoconazole.

Authors:  N Sonino
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

3.  Low-dose ketoconazole treatment in hirsute women.

Authors:  N Sonino; C Scaroni; A Biason; M Boscaro; F Mantero
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

4.  Fluconazole and testosterone: in vivo and in vitro studies.

Authors:  D P Hanger; S Jevons; J T Shaw
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

5.  Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol.

Authors:  M Terzolo; M Panarelli; A Piovesan; M Torta; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

6.  Interactions between xenoestrogens and ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua).

Authors:  Linda Hasselberg; Bjørn E Grøsvik; Anders Goksøyr; Malin C Celander
Journal:  Comp Hepatol       Date:  2005-02-08

Review 7.  Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?

Authors:  Ning Ding; Christopher Liddle; Ronald M Evans; Michael Downes
Journal:  Expert Rev Clin Pharmacol       Date:  2013-11       Impact factor: 5.045

8.  High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.

Authors:  A L Harris; B M Cantwell; M Dowsett
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

9.  Selective inhibition of steroidogenic enzymes by ketoconazole in rat ovary cells.

Authors:  Michael Gal; Joseph Orly
Journal:  Clin Med Insights Reprod Health       Date:  2014-02-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.